Detalles de la búsqueda
1.
Combined BCL-2 and PI3K/AKT Pathway Inhibition in KMT2A-Rearranged Acute B-Lymphoblastic Leukemia Cells.
Int J Mol Sci
; 24(2)2023 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36674872
2.
Exploring Thiazolopyridine AV25R: Unraveling of Biological Activities, Selective Anti-Cancer Properties and In Silico Target and Binding Prediction in Hematological Neoplasms.
Molecules
; 28(24)2023 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38138609
3.
The Inhibitory Response to PI3K/AKT Pathway Inhibitors MK-2206 and Buparlisib Is Related to Genetic Differences in Pancreatic Ductal Adenocarcinoma Cell Lines.
Int J Mol Sci
; 23(8)2022 Apr 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35457111
4.
Inhibitory Response to CK II Inhibitor Silmitasertib and CDKs Inhibitor Dinaciclib Is Related to Genetic Differences in Pancreatic Ductal Adenocarcinoma Cell Lines.
Int J Mol Sci
; 23(8)2022 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35457227
5.
Precursor B-ALL Cell Lines Differentially Respond to SYK Inhibition by Entospletinib.
Int J Mol Sci
; 22(2)2021 Jan 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33435587
6.
Combined Application of Pan-AKT Inhibitor MK-2206 and BCL-2 Antagonist Venetoclax in B-Cell Precursor Acute Lymphoblastic Leukemia.
Int J Mol Sci
; 22(5)2021 03 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33803402
7.
BTK and PI3K Inhibitors Reveal Synergistic Inhibitory Anti-Tumoral Effects in Canine Diffuse Large B-Cell Lymphoma Cells.
Int J Mol Sci
; 22(23)2021 Nov 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34884478
8.
Establishment and characterization of stable red, far-red (fR) and near infra-red (NIR) transfected canine prostate cancer cell lines.
Cancer Cell Int
; 20: 139, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32368185
9.
Influence of Casein kinase II inhibitor CX-4945 on BCL6-mediated apoptotic signaling in B-ALL in vitro and in vivo.
BMC Cancer
; 20(1): 184, 2020 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32131762
10.
Combined Casein Kinase II inhibition and epigenetic modulation in acute B-lymphoblastic leukemia.
BMC Cancer
; 19(1): 202, 2019 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30841886
11.
Phosphoproteome Analysis Reveals Differential Mode of Action of Sorafenib in Wildtype and Mutated FLT3 Acute Myeloid Leukemia (AML) Cells.
Mol Cell Proteomics
; 16(7): 1365-1376, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28450419
12.
Engraftment Efficiency after Intra-Bone Marrow versus Intravenous Transplantation of Bone Marrow Cells in a Canine Nonmyeloablative Dog Leukocyte Antigen-Identical Transplantation Model.
Biol Blood Marrow Transplant
; 23(2): 247-254, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27816649
13.
The novel arylindolylmaleimide PDA-66 displays pronounced antiproliferative effects in acute lymphoblastic leukemia cells.
BMC Cancer
; 14: 71, 2014 Feb 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-24502201
14.
Cross-Species Comparison of the Pan-RAF Inhibitor LY3009120's Anti-Tumor Effects in Equine, Canine, and Human Malignant Melanoma Cell Lines.
Genes (Basel)
; 15(2)2024 02 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38397192
15.
Spirooxindol-1,3-oxazine Alkaloids: Highly Potent and Selective Antitumor Agents Evolved from Iterative Structure Optimization.
ChemMedChem
; 17(14): e202200162, 2022 07 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35491398
16.
Effective tumor cell abrogation via Venetoclax-mediated BCL-2 inhibition in KMT2A-rearranged acute B-lymphoblastic leukemia.
Cell Death Discov
; 8(1): 302, 2022 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35778418
17.
The Molecular Subtype of Adult Acute Lymphoblastic Leukemia Samples Determines the Engraftment Site and Proliferation Kinetics in Patient-Derived Xenograft Models.
Cells
; 11(1)2022 01 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35011712
18.
Evaluation of the Synergistic Potential of Simultaneous Pan- or Isoform-Specific BET and SYK Inhibition in B-Cell Lymphoma: An In Vitro Approach.
Cancers (Basel)
; 14(19)2022 Sep 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36230614
19.
Inhibition of KRAS, MEK and PI3K Demonstrate Synergistic Anti-Tumor Effects in Pancreatic Ductal Adenocarcinoma Cell Lines.
Cancers (Basel)
; 14(18)2022 09 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36139627
20.
Pan- and Isoform-specific Inhibition of the Bromodomain and Extra-terminal Proteins and Evaluation of Synergistic Potential With Entospletinib in Canine Lymphoma.
Anticancer Res
; 40(7): 3781-3792, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32620617